SCHEMBL5886351

SCHEMBL5886351

CCc1cc(OC)nnc1Cn1ccnc1-c1cccc(F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ KDR P35968 2/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ GRIN2B Q13224 4/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ APLNR P35414 2/20 0.35
▸ PDGFRB P09619 1/20 0.34
▸ PDGFRA P16234 1/20 0.34
▸ GRIN1 Q05586 2/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ HSP90B1 P14625 1/20 0.34
▸ PTGDR2 Q9Y5Y4 1/20 0.34
▸ BRD4 O60885 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ CYP11B1 P15538 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5886305 0.92 ALDH1A1 (0.39) ALDH1A1NPSR1MAPTKDRMEN1
SCHEMBL5886328 0.90 ALDH1A1 (0.37) ALDH1A1NPSR1MAPTKDRMEN1
SCHEMBL4171889 0.85 ALDH1A1 (0.40) ALDH1A1NPSR1MAPTKDRMEN1
SCHEMBL5886317 0.83 BRD4 (0.40) ALDH1A1NPSR1MAPTKDRMEN1
SCHEMBL4166221 0.82 ALDH1A1 (0.38) ALDH1A1NPSR1MAPTKDRMEN1
SCHEMBL5886275 0.82 ALDH1A1 (0.35) ALDH1A1NPSR1MAPTKDRMEN1
SCHEMBL5886334 0.80 MAPT (0.39) ALDH1A1NPSR1MAPTKDRMEN1
SCHEMBL5886376 0.79 CYP1A1 (0.37) ALDH1A1NPSR1MAPTKDRMEN1
SCHEMBL5886243 0.79 PIK3CA (0.40) ALDH1A1NPSR1MAPTMEN1KMT2A
SCHEMBL4162740 0.78 ALDH1A1 (0.41) ALDH1A1NPSR1MAPTKDRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7122546-B2 Imidazol-1-ylmethyl pyridazine derivatives NEUROGEN CORPORATION (US) 2006-10-17 — — US claimed
US-20040077653-A1 Imidazol-1-ylmethyl pyridazine derivatives NEUROGEN CORPORATION 2004-04-22 — — US claimed
US-7122546-B2 Imidazol-1-ylmethyl pyridazine derivatives NEUROGEN CORPORATION (US) 2006-10-17 — — US disclosed
US-20040077653-A1 Imidazol-1-ylmethyl pyridazine derivatives NEUROGEN CORPORATION 2004-04-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077653-A1 Imidazol-1-ylmethyl pyridazine derivatives GABRA5, GABRA1, GABRA2 ALDH1A1 378/4885NPSR1 107/4885MAPT 986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback